Cinnamic Acid Derivatives as Anticancer Agents-A Review
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
1672-1703
Author(s):
P. De, M. Baltas and F. Bedos-Belval
Editorial [Hot Topic:Epigenetic Mechanisms and Therapeutic Strategies (Guest Editors: Victoria Samanidou and Leda Kovatsi)]
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
1732-1732
Author(s):
Victoria Samanidou and Leda Kovatsi
Epigenetically - Targeted Therapies for the Treatment of Hematological Malignancies
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
1757-1764
Author(s):
E. Georgiou and S. Kouidou
Discovery of Small Molecules that Target Autophagy for Cancer Treatment
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
1866-1873
Author(s):
L. Wu and B. Yan
Editorial [Hot Topic: Interferon Alpha2 in the Treatment of Hematological Malignancies. Status and Perspectives (Guest Editor: Hans Carl Hasselbalch)]
Journal:
Current Drug Targets
Volume:
12
Page:
387-391
Author(s):
Hans Carl Hasselbalch
Interferon-Alpha in the Treatment of Multiple Myeloma
Journal:
Current Drug Targets
Volume:
12
Page:
437-446
Author(s):
Teh Liane Khoo, Annette Juul Vangsted, Douglas Joshua and John Gibson
Editorial [Hot Topic: Targeting Tumor Uniquitin-Proteasome Pathway with New and Old Drugs (Guest Editor: Q. Ping Dou)]
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
236-238
Author(s):
Q. Ping Dou
Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
239-253
Author(s):
D. Chen, M. Frezza, S. Schmitt, J. Kanwar and Q. P. Dou
Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
254-284
Author(s):
G. K. Lloyd, M. A. Palladino, A. Younes, E. Valashi, M. A. Spear, C. M. Sloss, A. M. Roccaro, P. G. Richardson, F. Pajonk, H. Ovaa, Y. Oki, S. T.C. Neuteboom, C. P. Miller, D. J. McConkey, W. McBride, B. C. Potts, K. S. Lam, P. R. Jensen, M. Groll, I. M. Ghobrial, W. Fenical, J. C. Cusack, D. Chauhan, J. Chandra, B. Bonavida, C. Berkers, S. Baritaki, K. C. Anderson and M. X. Albitar
Second Generation Proteasome Inhibitors: Carfilzomib and Immunoproteasome-Specific Inhibitors (IPSIs)
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
285-295
Author(s):
D. J. Kuhn, R. Z. Orlowski and C. C. Bjorklund